Literature DB >> 9424092

Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1.

Y Shirakata1, M Amagai, Y Hanakawa, T Nishikawa, K Hashimoto.   

Abstract

Oral mucosal lesions are seen in most cases of pemphigus vulgaris, whereas they are only rarely seen in pemphigus foliaceus; however, both pemphigus vulgaris and pemphigus foliaceus sera show positive immunofluorescence staining on oral mucosa. To explain this apparent paradox, we examined the expression level of desmoglein (Dsg)3, pemphigus vulgaris antigen, and Dsg1, pemphigus foliaceus antigen, in human squamous mucosal epithelia and epidermis by immunofluorescence staining and immunoblotting. For immunofluorescence staining, Dsg isotype-specific antibodies were produced by immunoadsorbing pemphigus vulgaris sera with either recombinant Dsg1 or Dsg3 baculoprotein. In oral mucosa and esophagus both Dsg were immunoreactive on cell surfaces throughout the entire epithelia, but staining intensity was weaker for Dsg1 than for Dsg3. Immunoblotting was performed to compare Dsg1 and Dsg3 expression levels in extracts from epidermis and oral mucosa. The total amount of desmosomal proteins applied was adjusted to give the same degree of staining intensity for desmoplakin, a cytoplasmic plaque protein of desmosomes. In the mucosal extract, the Dsg1 band was much weaker than Dsg3, whereas in the epidermal extract the Dsg1 band was stronger than Dsg3. These data suggest that although Dsg1 and Dsg3 are expressed in a similar distribution throughout squamous mucosal epithelia, Dsg1 is expressed at a much lower level than Dsg3. This finding provides a good explanation for the paradox: even though anti-Dsg1 autoantibodies block the function of Dsg1 in the mucosal epithelia, Dsg3 may be sufficient for cell-cell adhesion, with consequently no apparent oral involvement in pemphigus foliaceus patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9424092     DOI: 10.1046/j.1523-1747.1998.00085.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  34 in total

1.  p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.

Authors:  Xuming Mao; Yasuyo Sano; Jin Mo Park; Aimee S Payne
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

2.  Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin.

Authors:  Lina Williamson; Natalia A Raess; Reto Caldelari; Anthony Zakher; Alain de Bruin; Horst Posthaus; Reinhard Bolli; Thomas Hunziker; Maja M Suter; Eliane J Müller
Journal:  EMBO J       Date:  2006-07-26       Impact factor: 11.598

Review 3.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 4.  Diagnosis and clinical features of pemphigus foliaceus.

Authors:  Kirk A James; Donna A Culton; Luis A Diaz
Journal:  Dermatol Clin       Date:  2011-07       Impact factor: 3.478

Review 5.  Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases.

Authors:  Michael Olbrich; Axel Künstner; Mareike Witte; Hauke Busch; Anke Fähnrich
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

6.  Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.

Authors:  Aimee S Payne; Ken Ishii; Stephen Kacir; Chenyan Lin; Hong Li; Yasushi Hanakawa; Kazuyuki Tsunoda; Masayuki Amagai; John R Stanley; Don L Siegel
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 7.  Update on fogo selvagem, an endemic form of pemphigus foliaceus.

Authors:  Valeria Aoki; Evandro A Rivitti; Luis A Diaz
Journal:  J Dermatol       Date:  2015-01       Impact factor: 4.005

8.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.

Authors:  M Amagai; T Nishikawa; H C Nousari; G J Anhalt; T Hashimoto
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 9.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

10.  Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies.

Authors:  Ken Ishii; Chenyan Lin; Don L Siegel; John R Stanley
Journal:  J Invest Dermatol       Date:  2007-11-15       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.